Dextera Surgical Inc. (DXTR) Is Worth Paying Attention

Dextera Surgical Inc. (NASDAQ:DXTR) marched up 14.29% compared to a 52-week low price of $0.02. The shares were last seen trading -15.97% lower, taking the closing price at $0.02 on 03/13/2018. At recent session, the prices were hovering between $0.02 and $0.0224. This company shares are -100% up from its target price of $0 and the current market capitalization stands at $880000. The recent change has given its price a -42.82% deficit over SMA 50 and -98.44% deficit over its 52-week high. The stock witnessed -42.2% declines, -85.71% declines and -93.93% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found DXTR’s volatility during a week at 19.74% and during a month it has been found around 19.79%.

Last month, it obtained approval by the Bankruptcy Court for the sale of substantially all of Dextera Surgical’s assets to Aesculap, Inc., a B. Braun company. The transaction was expected to be completed by February 20, 2018.

“We are pleased to see our innovative MicroCutter 5/80 Stapler, PAS-Port® and C-Port® automated anastomosis system cardiac surgery products and technology portfolio transitioning into the very capable hands of the team at Aesculap, Inc. to provide a path for these products to remain in the hands of surgeons and be supported around the globe,” said Julian Nikolchev, president and CEO of Dextera Surgical. “We are working with the Aesculap, Inc. team to transition the manufacturing and worldwide marketing and support of the MicroCutter 5/80, PAS-Port Proximal and C-Port Distal Anastomosis Systems.”

Dextera Surgical Inc. (NASDAQ:DXTR) Insider Trades

Multiple company employees have indulged in significant insider trading. Dextera Surgical Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that COO Palermo Thomas J. has acquired 6,300 shares of Dextera Surgical Inc. (DXTR) in trading session dated May. 16, 2016. These shares are worth $16,506 and were traded at $2.62 each. The SEC filing shows that Bates Michael A. performed a purchase of 35,400 shares. The Director added these shares by way of transaction on Feb. 29, 2016. The company’s shares were assimilated at $3.53 per share worth to an investment of some $124,962 on account of Bates Michael A..

COO, Palermo Thomas J., purchased 7,500 common shares of Dextera Surgical Inc. (DXTR) in the open market. In a transaction dated Feb. 26, 2016, the shares were bought at an average price of $3.77, giving away a sum of $28,275. After this purchase, 7,500 common shares of DXTR are directly owned by the insider, with total stake valued at $150.

In the transaction dated Feb. 24, 2016, the great number of shares acquired came courtesy the Director; Bates Michael A. added a total of 33,600 shares at an average price of $2.91, amounting to approximately $97,776. The insider now directly owns 54,600 shares worth $1,092.

Dextera Surgical Inc. (DXTR) Analyst Guide

Several analysts have released their opinion on Dextera Surgical Inc. (NASDAQ:DXTR), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation.

Previous articleHedge Funds Now Own 48.8% Of Curis, Inc. (CRIS)
Next articleRXi Pharmaceuticals Corporation (RXII) Stock Ownership And Insider News